A detailed history of Blackstone Inc transactions in Alector, Inc. stock. As of the latest transaction made, Blackstone Inc holds 25,715 shares of ALEC stock, worth $47,829. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,715
Previous 25,715 -0.0%
Holding current value
$47,829
Previous $116,000 3.45%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.19 - $6.23 $43,098 - $64,081
10,286 Added 66.67%
25,715 $116,000
Q3 2023

Nov 14, 2023

BUY
$5.2 - $8.77 $26,743 - $45,104
5,143 Added 50.0%
15,429 $99,000
Q4 2022

Feb 14, 2023

BUY
$6.88 - $9.55 $70,767 - $98,231
10,286 New
10,286 $94,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $154M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Blackstone Inc Portfolio

Follow Blackstone Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackstone Inc, based on Form 13F filings with the SEC.

News

Stay updated on Blackstone Inc with notifications on news.